Can prosthesis type influence the recurrence of infective endocarditis after surgery for native valve endocarditis? A propensity weighted comparison. (19th May 2021)
- Record Type:
- Journal Article
- Title:
- Can prosthesis type influence the recurrence of infective endocarditis after surgery for native valve endocarditis? A propensity weighted comparison. (19th May 2021)
- Main Title:
- Can prosthesis type influence the recurrence of infective endocarditis after surgery for native valve endocarditis? A propensity weighted comparison
- Authors:
- Rubino, Antonino S
Della Ratta, Ester E
Galbiati, Denise
Ashurov, Rasul
Galgano, Viviana L
Montella, Antonio P
De Feo, Marisa
Della Corte, Alessandro - Abstract:
- Abstract: : OBJECTIVES: Our goal was to investigate whether the incidence of valve-related adverse events might be different depending on the valve substitute after valve replacement for left-sided native valve endocarditis. METHODS: We assessed the long-term freedom from recurrence, reoperation and survival of 395 patients who had valve replacements for native valve endocarditis (314 mechanical vs 81 biological). Age <18 years, reoperation, prosthetic endocarditis, right valve involvement, valve repair and homograft implants were the main exclusion criteria. The balance between the 2 groups was addressed by weighting the results on the inverse of the propensity score. RESULTS: After inverse probability of treatment weighting (IPTW), freedom from recurrence of infective endocarditis was not significantly different (mechanical 84.1 ± 3.2% vs 50.6 ± 21.7%; P = 0.29) nor was freedom from reoperation different (mechanical 85.7 ± 3.1% vs biological 50.9 ± 21.9%; P = 0.29). Excluding competing deaths, patients receiving a bioprosthesis had a similar subdistribution hazard of the above end points compared to recipients of a mechanical valve [recurrence IPTW: hazard ratio (HR) 1.631, 95% confidence interval (CI) 0.756–3.516; P = 0.21; reoperation IPTW-HR 1.737, 95% CI 0.780–3.870; P = 0.18]. Mechanical valves were associated with improved long-term survival (34.9 ± 5.8% vs 10.5 ± 7.4% at 30 years; P = 0.0009; in particular: aortic valve subgroup 41.6 ± 9.3% vs 10.1 ± 8.2%; PAbstract: : OBJECTIVES: Our goal was to investigate whether the incidence of valve-related adverse events might be different depending on the valve substitute after valve replacement for left-sided native valve endocarditis. METHODS: We assessed the long-term freedom from recurrence, reoperation and survival of 395 patients who had valve replacements for native valve endocarditis (314 mechanical vs 81 biological). Age <18 years, reoperation, prosthetic endocarditis, right valve involvement, valve repair and homograft implants were the main exclusion criteria. The balance between the 2 groups was addressed by weighting the results on the inverse of the propensity score. RESULTS: After inverse probability of treatment weighting (IPTW), freedom from recurrence of infective endocarditis was not significantly different (mechanical 84.1 ± 3.2% vs 50.6 ± 21.7%; P = 0.29) nor was freedom from reoperation different (mechanical 85.7 ± 3.1% vs biological 50.9 ± 21.9%; P = 0.29). Excluding competing deaths, patients receiving a bioprosthesis had a similar subdistribution hazard of the above end points compared to recipients of a mechanical valve [recurrence IPTW: hazard ratio (HR) 1.631, 95% confidence interval (CI) 0.756–3.516; P = 0.21; reoperation IPTW-HR 1.737, 95% CI 0.780–3.870; P = 0.18]. Mechanical valves were associated with improved long-term survival (34.9 ± 5.8% vs 10.5 ± 7.4% at 30 years; P = 0.0009; in particular: aortic valve subgroup 41.6 ± 9.3% vs 10.1 ± 8.2%; P < 0.0001), although the hazard of cardiovascular mortality did not favour either valve type (IPTW: HR 1.361, 95% CI 0.771–2.404; P = 0.29). CONCLUSIONS: Our analysis showed a clinical trend in favour of mechanical valves as valve substitutes for native valve endocarditis, especially in the aortic position. In view of long-term freedom from adverse events, the choice of the valve type should be tailored according to patient characteristics and specific clinical conditions. Abstract : Infective endocarditis is a challenging clinical condition, secondary to an infection of the valvular endothelium and the paravalvular apparatus, which deserves cardiac surgery to eradicate the infection and to re-establish adequate valve competence [1, 2]. … (more)
- Is Part Of:
- European journal of cardio-thoracic surgery. Volume 60:Number 6(2021)
- Journal:
- European journal of cardio-thoracic surgery
- Issue:
- Volume 60:Number 6(2021)
- Issue Display:
- Volume 60, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 60
- Issue:
- 6
- Issue Sort Value:
- 2021-0060-0006-0000
- Page Start:
- 1388
- Page End:
- 1394
- Publication Date:
- 2021-05-19
- Subjects:
- Endocarditis -- Recurrence -- Reoperation -- Prosthesis -- Survival
Heart -- Surgery -- Periodicals
Chest -- Surgery -- Periodicals
617.54 - Journal URLs:
- http://ejcts.oxfordjournals.org/ ↗
http://www.sciencedirect.com/science/journal/10107940 ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/ejcts/ezab238 ↗
- Languages:
- English
- ISSNs:
- 1010-7940
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725620
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25137.xml